🇺🇸 FDA
Patent

US 6251926

Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity

expired A61KA61K31/42A61K31/421

Quick answer

US patent 6251926 (Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity) held by Takeda Chemical Industries Ltd. expires Mon Jun 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Takeda Chemical Industries Ltd.
Grant date
Tue Jun 26 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61K, A61K31/42, A61K31/421, A61K31/4245, A61K31/426